A Form 4 filed on September 10, 2026 disclosed that Glenn S. Boehnlein, a director of DexCom Inc (NASDAQ:DXCM), received a grant of 5,841 restricted stock units at a price of $0 on September 10, 2026.
Key Highlights
- RSU Grant: Boehnlein acquired 5,841 restricted stock units in a transaction coded "A" (acquired) at $0 on September 10, 2026.
- Vesting Schedule: The RSUs vest in three equal annual installments from the date of grant, according to the filing.
- Nature of Award: The filing states the grant is "exempt from Section 16b-3" and each RSU represents "a contingent right to receive one share of DexCom, Inc. Common Stock."
- Direct Ownership Following Transaction: Boehnlein directly holds 5,841 shares of common stock following the reported transaction.
- Indirect Ownership: An additional 42 shares are held indirectly by the Boehnlein 2017 Trust, of which the reporting person and spouse are co-trustees.
DexCom Director RSU Grant Details and Resulting Ownership
According to the Form 4 filed with the SEC, Glenn S. Boehnlein, identified as a Director of DexCom Inc (NASDAQ:DXCM), received a grant of 5,841 restricted stock units on September 10, 2026. The transaction was coded "A," indicating an acquisition, and the price listed is $0. The filing notes the grant is "exempt from Section 16b-3" and that the RSUs are "subject to vesting in three equal annual installments from the date of grant."
Following the reported transaction, the filing shows Boehnlein directly beneficially owns 5,841 shares of DexCom common stock. The filing also discloses that 42 shares of common stock are held indirectly through the Boehnlein 2017 Trust, with the reporting person and the reporting person's spouse serving as co-trustees.
The Form 4 was signed by Jereme M. Sylvain as Attorney-in-Fact for Glenn S. Boehnlein on September 10, 2026. No derivative securities transactions were reported in Table II of the filing.
What Was Disclosed
DexCom director Glenn S. Boehnlein reported the acquisition of 5,841 restricted stock units at $0, vesting in three equal annual installments. He directly holds 5,841 shares following the grant, with an additional 42 shares held indirectly via a trust.




Please wait processing your request...